Similar articles

• Clinical practice update on testosterone therapy for male hypogonadism: Contrasting perspectives to optimize care.

  Yeap BB, Wu FCW. Yeap BB, et al. Clin Endocrinol (Oxf). 2019 Jan;90(1):56-65. doi: 10.1111/cen.13888. Epub 2018 Dec 3. Clin Endocrinol (Oxf). 2019. PMID: 30358898 Review.
• Clinical practice guidelines for screening and monitoring male patients receiving testosterone supplementation therapy.

  Morales A, Bain J, Ruijs A, Chapdelaine A, Tremblay RR. Morales A, et al. Int J Impot Res. 1996 Jun;8(2):95-7. Int J Impot Res. 1996. PMID: 8858399 No abstract available.
• Approaches to male hypogonadism in primary care.

  Lawrence KL, Stewart F, Larson BM. Lawrence KL, et al. Nurse Pract. 2017 Feb 12;42(2):32-37. doi: 10.1097/01.NPR.0000511774.51873.da. Nurse Pract. 2017. PMID: 28085783 Free PMC article.
• Clinical hypogonadism and androgen replacement therapy: an overview.

  Ohl DA, Quallich SA. Ohl DA, et al. Urol Nurs. 2006 Aug;26(4):253-9, 269; quiz 260. Urol Nurs. 2006. PMID: 16939042 Review.
• Evaluation and Treatment of Male Hypogonadism.

  Sargis RM, Davis AM. Sargis RM, et al. JAMA. 2018 Apr 3;319(13):1375-1376. doi: 10.1001/jama.2018.3182. JAMA. 2018. PMID: 29550857 No abstract available.